Subscribe for the newsletter
Articles
Expert Interviews
Roundtable
Press Releases
Videos
The Road To Series
Market Research
Thought Leaders
More
Discovery
Small Molecules
Biologics
Advanced Therapies
Manufacturing
Supply Chain
Clinical Trials
Technologies
Financing
Capacity Expansion
Sort By
Newest First
Sign in
1 / 5
1 / 5
Capacity Expansion
CiVentiChem Increases Capacity by 300% with New Facility; Celebrates 30th Anniversary
CiVentiChem
PR-08-24-NI-02
Aug 13, 2024
Expansion
Vetter looks ahead to further expansions to meet supply chain demand
Vetter Pharma International GmbH
PR-M10-23-03
Oct 17, 2023
CDMO Service and Capacity Expansion
Pharma Service Provider Further Expands Offerings for Clinical Development and Manufacturing
Vetter Pharma International GmbH
PR-M05-23-01
May 09, 2023
New Biomanufacturing Facility
Samsung Biologics Announces Construction of Plant 5 to Commence Bio Campus II Capacity Expansion
Samsung Biologics
PR-M03-23-05
Mar 17, 2023
High Containment
Olon, Leading International API Supplier, Announces A New Investment That Will Further Expand its Global High Containment Platform a New High Containment Line in the Site Located in India
Olon
PR-M09-22-06
Sep 27, 2022
Manufacturing Investment
MilliporeSigma Announces Investment of More Than € 130 Million to Strengthen Manufacturing Capabilities in Molsheim, France
MilliporeSigma
PR-M09-22-02
Sep 08, 2022
Acquisition and Rebranding
Dr. Glenn Haifer and Ampersand Capital Partners Acquire Australian Biologics CDMO Luina Bio, Rebranding as AcuraBio
AcuraBio
PR-M09-22-01
Sep 07, 2022
Site Expansion
Vetter’s Newest Clinical Manufacturing Site Successfully Completed Its First Customer Fills
Vetter Pharma International GmbH
PR-M06-22-07
Jun 28, 2022
Capacity Expansion
Avid Bioservices Announces Further Expansion of Process Development Capacity for Mammalian Cell Business
Avid Bioservices
PR-M06-22-02
Jun 13, 2022
New Facility
AGC Biologics Invests in Viral Vector Suspension at New U.S. Campus
AGC Biologics
PR-M05-22-13-359
May 18, 2022
Financial Results
Samsung Biologics Reports First Quarter 2022 Financial Results
Samsung Biologics
PR-M04-22-14
Apr 27, 2022
Vaccine and Cell & Gene Therapies
Expanding Manufacturing Capacity to Meet Market Demand for Vaccines and Cell and Gene Therapeutics
lrike Fiedler Dr. Rer. Nat.
IDT Biologika
PAO-04-022-CL-02
Apr 13, 2022
Ambient Storage
Yourway Adds Additional Capacity for Controlled Ambient Storage in Allentown, PA
Yourway
PR-M04-22-07
Apr 12, 2022
Facility Acquisition
Fujifilm Completes Acquisition of a Dedicated Cell Therapy Manufacturing Facility from Atara Biotherapeutics, Inc.
Fujifilm Diosynth Biotechnologies
PR-M04-22-01
Apr 04, 2022
Facility Expansion
Alcami Expands Biopharma Storage at Masy BioServices
Alcami
PR-M03-22-15
Mar 29, 2022
Mergers and Acquisitions
Integrating Services Across the Full Spectrum of Cell and Gene Therapy
ProtaGene
PAO-02-22-R250-10
Feb 11, 2022
Vaccines
IDT Biologika is Increasing its Production Capacity of Vaccines – Saxony-Anhalt's Prime Minister Reiner Haseloff Visited the New Facilities
IDT Biologika
PR-M01-22-13
Jan 20, 2022
Expansion
FDA Accepts GMP Plasmid DMF and Capacity Expansion Enabling Andelyn Biosciences to Offer Faster Gene Therapy Development
Andelyn Biosciences
PR-M01-22-10
Jan 13, 2022
Biologics
An Evolving Biologics Landscape and Driving Innovation and Opportunity
Tim Roberts
PCI Pharma Services
PAO-11-21-CL-16
Nov 30, 2021
Expansion
German CDMO Richter-Helm Expands Plant to Serve Demand for Biologics Manufacturing
Richter-Helm BioLogics
PAO-07-21-CL-08
Jul 23, 2021
